We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics

News   May 09, 2017 | Original story from Oxford Genetics

 
Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics
 
 
 

RELATED ARTICLES

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

Personalized Implants Designed to Improve Organ Transplant Success

News

Host-derived scaffolding material may reduce the chance of organ transplant rejection.

READ MORE

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE